Enlightenment from clinical trials on Chinese medicine for coronavirus disease 2019 (COVID-19).

Pang, Bo; Zhang, Junhua; Lee, Myeong Soo; Zheng, Wenke
Integrative medicine research
2020Sep ; 9 ( 3 ) :100481.
ÀúÀÚ »ó¼¼Á¤º¸
Pang, Bo - Evidence-Based Medicine Center, Tianjin University of Traditional Chinese Medicine, Tianjin, China.
Zhang, Junhua - Evidence-Based Medicine Center, Tianjin University of Traditional Chinese Medicine,
Lee, Myeong Soo - Clinical Medicine Division, Korea Institute of Oriental Medicine, Daejeon, South
Zheng, Wenke - Evidence-Based Medicine Center, Tianjin University of Traditional Chinese Medicine,
ABSTRACT
COVID-19; Clinical trials; Traditional Chinese Medicine
¸µÅ©

ÁÖÁ¦ÄÚµå
ÁÖÁ¦¸í(Target field)
¿¬±¸´ë»ó(Population)
¿¬±¸Âü¿©(Sample size)
´ë»ó¼ºº°(Gender)
Áúº´Æ¯¼º(Condition Category)
¿¬±¸È¯°æ(Setting)
¿¬±¸¼³°è(Study Design)
¿¬±¸±â°£(Period)
ÁßÀç¹æ¹ý(Intervention Type)
ÁßÀç¸íĪ(Intervention Name)
Å°¿öµå(Keyword)
À¯È¿¼º°á°ú(Recomendation)
This review found 26 published clinical controlled trials of TCM for COVID-19, and 11 of them were RCTs with 1301 patients. However, none of them were placebo-controlled and double-blinded RCTs. The types of patients, interventions and outcomes in different RCTs varied significantly; most of the published trials have not registered their protocols before case recruitment.
¿¬±¸ºñÁö¿ø(Fund Source)
±Ù°Å¼öÁØÆò°¡(Evidence Hierarchy)
ÃâÆdz⵵(Year)
Âü¿©ÀúÀÚ¼ö(Authors)
´ëÇ¥ÀúÀÚ
DOI
10.1016/j.imr.2020.100481
KCDÄÚµå
ICD 03
°Ç°­º¸ÇèÄÚµå